Merantix Capital

Activity from announced rounds

Activity in this selectionSeries A
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$23.5M
2 disclosed · full round size, not this investor’s share

By stage

Series A2

By primary sector

Biotech1
Industrial tech1

By country

Austria1
Germany1

Rounds

2 in this selection
Almetra

Manufacturing software that combines production video, machine data and operator feedback to explain losses and guide improvements.

€16.3MSeries A
Role not disclosed
Graph Therapeutics

Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis

$5MSeries A
Role not disclosed